05/06/2026
Congratulations to South Africa on the launch of lenacapavir, the twice-yearly injectable PrEP – a historic step forward in the fight to prevent HIV and a powerful example of what is possible when scientific innovation, political leadership and community action come together.
For the first time, a major HIV prevention innovation is being rolled out in low- and middle-income countries at the same time as in high-income countries – an important milestone for health equity.
South Africa is helping shape the future of HIV prevention by showing how breakthrough innovations can be rapidly translated into impact for the communities most affected by HIV.
The scale and speed of this rollout reflect decades of leadership by communities, activists, health workers and public institutions – and a clear commitment to reducing new infections faster and bringing the end of HIV as a public health threat within reach.
The Global Fund is proud to be a partner in this effort.
Cyril Ramaphosa | The Presidency of the Republic of South Africa